特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
918134

腎臓癌治療薬の世界市場:2020年

Kidney Cancer Drugs Global Market Report 2020

出版日: | 発行: The Business Research Company | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
腎臓癌治療薬の世界市場:2020年
出版日: 2019年12月09日
発行: The Business Research Company
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の腎臓癌治療薬市場について調査しており、市場の動向および戦略、市場の成長および阻害要因、タイプ・製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場規模および成長

  • 過去の市場
  • 市場の予測
    • 市場の成長要因
    • 市場の阻害要因

第4章 市場セグメンテーション

  • タイプ別:過去/予測
    • 腎細胞がん(RCC)
    • 移行上皮癌(TCC)/尿路上皮癌(UCC)
  • 製品別:過去/予測
    • ネクサバール(ソラフェニブ)
    • スーテン(スニチニブ)
    • アフィニトール(エベロリムス)
    • ヴォトリエント(パゾパニブ)
    • アバスチン(ベバシズマブ)
    • インリタ(アキシチニブ)、
    • トリセル(テムシロリムス)
    • プロロイキン(アルデスロイキン)
    • その他
  • エンドユーザー別:過去/予測
    • 病院
    • 診療所
    • 研究所
    • その他

第5章 市場分析:地域/国別

  • 市場の過去/予測:地域別
  • 市場の過去/予測:国別

第6章 アジア太平洋地域市場

  • 市場の概要
  • 市場の過去/予測:タイプ別
  • 市場の過去/予測:製品別
  • 市場の過去/予測:エンドユーザー別

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧市場

第18章 ロシア市場

第19章 北米市場

第20章 米国市場

第21章 南米市場

第22章 ブラジル市場

第23章 中東市場

第24章 アフリカ市場

第25章 競合情勢および企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Bayer AG
    • Pfizer Inc
    • Novartis International AG
    • Exelixis, Inc
    • F. Hoffmann-La Roche Ag

第26章主な合併および買収

第27章 市場の動向および戦略

第28章 製品パイプライン分析

第29章 市場の今後の見通しおよびポテンシャル分析

第30章 付録

  • 略語
  • 通貨
  • 調査に関するお問い合わせ
  • ビジネスリサーチ企業
  • 著作権および免責事項
目次

Kidney Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the kidney cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Kidney Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib),, Torisel (Temsirolimus), Proleukin (Aldesleukin), Others 3) By End Users: Hospitals, Clinics, Research Center, Others

Companies Mentioned: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Kidney Cancer Drugs Market Characteristics

3. Kidney Cancer Drugs Market Size And Growth

  • 3.1. Global Kidney Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Kidney Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Kidney Cancer Drugs Market Segmentation

  • 4.1. Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Renal Cell Carcinoma (RCC)
    • Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC)
  • 4.2. Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Nexavar (Sorafenib)
    • Sutent (Sunitinib)
    • Afinitor (Everolimus)
    • Votrient (Pazopanib)
    • Avastin (Bevacizumab)
    • Inlyta (Axitinib),
    • Torisel (Temsirolimus)
    • Proleukin (Aldesleukin)
    • Others
  • 4.3. Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Research Center
    • Other

5. Kidney Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Kidney Cancer Drugs Market

  • 6.1. Asia-Pacific Kidney Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.4. Asia-Pacific Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Kidney Cancer Drugs Market

  • 7.1. China Kidney Cancer Drugs Market Overview
  • 7.2. China Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.4. China Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Kidney Cancer Drugs Market

  • 8.1. India Kidney Cancer Drugs Market Overview
  • 8.2. India Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.4. India Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Kidney Cancer Drugs Market

  • 9.1. Japan Kidney Cancer Drugs Market Overview
  • 9.2. Japan Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.4. Japan Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Kidney Cancer Drugs Market

  • 10.1. Australia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.3. Australia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Kidney Cancer Drugs Market

  • 11.1. Indonesia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.3. Indonesia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Kidney Cancer Drugs Market

  • 12.1. South Korea Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.3. South Korea Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Kidney Cancer Drugs Market

  • 13.1. Western Europe Kidney Cancer Drugs Market Overview
  • 13.2. Western Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.4. Western Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Kidney Cancer Drugs Market

  • 14.1. UK Kidney Cancer Drugs Market Overview
  • 14.2. UK Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.4. UK Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Kidney Cancer Drugs Market

  • 15.1. Germany Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.3. Germany Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Kidney Cancer Drugs Market

  • 16.5. France Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.6. France Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.7. France Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Kidney Cancer Drugs Market

  • 17.1. Eastern Europe Kidney Cancer Drugs Market Overview
  • 17.2. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.4. Eastern Europe Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Kidney Cancer Drugs Market

  • 18.1. Russia Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.3. Russia Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Kidney Cancer Drugs Market

  • 19.1. North America Kidney Cancer Drugs Market Overview
  • 19.2. North America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.4. North America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Kidney Cancer Drugs Market

  • 20.1. USA Kidney Cancer Drugs Market Overview
  • 20.2. USA Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.4. USA Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Kidney Cancer Drugs Market

  • 21.1. South America Kidney Cancer Drugs Market Overview
  • 21.2. South America Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.4. South America Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Kidney Cancer Drugs Market

  • 22.1. Brazil Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.3. Brazil Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Kidney Cancer Drugs Market

  • 23.1. Middle East Kidney Cancer Drugs Market Overview
  • 23.2. Middle East Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.4. Middle East Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Kidney Cancer Drugs Market

  • 24.1. Africa Kidney Cancer Drugs Market Overview
  • 24.2. Africa Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.4. Africa Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Kidney Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Kidney Cancer Drugs Market Competitive Landscape
  • 25.2. Kidney Cancer Drugs Market Company Profiles
    • 25.2.1. Bayer AG
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Pfizer Inc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis International AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Exelixis, Inc
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. F. Hoffmann-La Roche Ag
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Kidney Cancer Drugs Market

27. Kidney Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Kidney Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.